Potentiation of adenosine A1 receptor agonist CPA-induced antinociception by paeoniflorin in mice

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 8, 2006, Pages 1630-1633

  Liu, Da Zhi ^a   Zhao, Fei Li ^a   Liu, Jing ^a   Li, Xin Quan ^a   Ye, Yang ^a   Zhu, Xing Zu ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Adenosine; Adenosine A1 receptor; Antinociception; Paeoniflorin

Indexed keywords

6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR AGONIST; PAEONIFLORIN; ADENOSINE; ADENOSINE A1 RECEPTOR; ANALGESIC AGENT; BENZOIC ACID DERIVATIVE; BRIDGED COMPOUND; DRUG DERIVATIVE; GLUCOSIDE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRESSURE; RAT; TAIL; ANIMAL; RADIOASSAY;

ADENOSINE; ANALGESICS; ANIMALS; BENZOIC ACIDS; BRIDGED COMPOUNDS; GLUCOSIDES; MALE; MICE; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A1;

EID: 33746765075     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1630     Document Type: Article

References (23)

1. Shibata T., Morimoto T., Suzauki A., Saito H., Yanaihara T., Acta Obst. Gynaecol. Jpn., 48, 321-327 (1996).
2. Tanaka T., Clin. Exp. Obstet. Gynecol., 30, 95-98 (2003).
3. Wu Y. X., Zhang X. M., Yuan S., Wang S. Q., Zhang S. P., Sh. J. Trad. Chin. Med., 6, 16-17 (1988).
4. Kobayashi M., Ueda C., Aoki S., Taiima K., Tanaka N., Yamahara J., Yakugaku Zasshi, 110, 964-968 (1990).
5. Tsai H.Y., Lin Y. T., Tsai C. H., Chen Y. F., J. Ethnopharmacol., 75, 267-271 (2001).
6. Cheng J. T., Wang C. J., Hsu F. L., Clin. Exp. Pharmacol. Physiol., 26, 815-816 (1999).
7. Lai C. W., Hsu F. L., Cheng J. T., Life Sci., 62, 1591-1595 (1998).
8. Tang L. M., Liu I. M., Cheng J. T., Planta Med., 69, 332-336 (2003).
9. Liu D. Z., Xie K. Q., Ji X.Q., Ye Y., Jiang C. L., Zhu X. Z., Br. J. Pharmacol., 146, 604-611 (2005).
10. Sawynok J., Eur. J. Pharmacol., 347, 1-11 (1998).
11. Tjolsen A., Berge O. G., Hunskaar S., Rosland J. H., Hole K., Pain, 51, 5-17 (1992).
12. Sawynok J., Reid A., Poon A., Pain, 74, 75-81 (1998).
13. Dickenson A. H., Suzuki R., Reeve A. J., CNS Drugs, 13, 77-85 (2000).
14. Sawynok J., Reid A., Liu X. J., Eur. J. Pharmacol., 386, 253-261 (1999).
15. Hata T., Kita T., Itoh E., Kawabata A., J. Auton. Pharmacol., 8, 45-52 (1988).
16. Chen F., Lu H. T., Jiang Y., J. Chromatogr. A., 1040, 205-208 (2004).
17. Yin L. L., Zhu X. Z., Pharmacol. Biochem. Behav., 80, 419-425 (2005).
18. Finlayson K., Butcher S. P., Sharkey J., Olyverman H. J., J. Neurosci. Meth., 77, 135-142 (1997).
19. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
20. Sawynok J., Liu X. J., Progr. Neurobiol., 69, 313-340 (2003).
21. Greene R. W., Haas H. L., Progr. Neurobiol., 36, 329-341 (1991).
22. Snyder S. H., Ann. Rev. Neurosci., 8, 103-124 (1985).
23. Contreras E., Germany A., Villar M., Gen. Pharmac., 21, 763-767 (1990).